Leonardo Ferrari

Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors

Emilio Bajetta, Leonardo Ferrari, Antonia Martinetti et al. · Cancer · 1999 · 289 citations

Medicine, Endocrinology, Oncology +16

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

Emilio Bajetta, Laura Catena, Giuseppe Procopio et al. · Cancer Chemotherapy and Pharmacology · 2006 · 241 citations

Medicine, Oncology, Pharmacology +12

Lanreotide autogel every 6 weeks compared with Lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors

Emilio Bajetta, Giuseppe Procopio, Laura Catena et al. · Cancer · 2006 · 65 citations · Full text

Medicine, Oncology, Pharmacology +9

Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine study.

Luigi Celio, Antonia Martinetti, Leonardo Ferrari et al. · PubMed · 1999 · 52 citations

Medicine, Endocrinology, Pharmacology +17

Neuron-Specific Enolase Evaluation in Patients with Neuroblastoma

Simonetta Massaron, Ettore Seregni, Roberto Luksch et al. · Tumor Biology · 1998 · 42 citations

Medicine, Oncology, Neuro-oncology +12